First Horizon Advisors Inc. Cuts Holdings in Kenvue Inc. $KVUE

First Horizon Advisors Inc. lowered its position in Kenvue Inc. (NYSE:KVUE) by 17.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,456 shares of the company’s stock after selling 4,231 shares during the quarter. First Horizon Advisors Inc.’s holdings in Kenvue were worth $428,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Kenvue by 4.9% in the 1st quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock worth $5,494,882,000 after purchasing an additional 10,600,682 shares during the period. Charles Schwab Investment Management Inc. increased its position in Kenvue by 2.5% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 25,606,238 shares of the company’s stock worth $613,882,000 after purchasing an additional 633,461 shares in the last quarter. Boston Partners raised its holdings in Kenvue by 7.4% in the first quarter. Boston Partners now owns 25,346,453 shares of the company’s stock valued at $606,920,000 after buying an additional 1,750,490 shares during the period. JPMorgan Chase & Co. lifted its position in Kenvue by 11.6% during the first quarter. JPMorgan Chase & Co. now owns 24,912,226 shares of the company’s stock valued at $597,395,000 after buying an additional 2,597,920 shares in the last quarter. Finally, American Century Companies Inc. lifted its position in Kenvue by 15.7% during the first quarter. American Century Companies Inc. now owns 21,828,854 shares of the company’s stock valued at $523,456,000 after buying an additional 2,961,716 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on KVUE. Citigroup dropped their price objective on shares of Kenvue from $20.00 to $17.00 and set a “neutral” rating for the company in a research report on Thursday, October 9th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a report on Tuesday, October 14th. Canaccord Genuity Group restated a “hold” rating and set a $15.00 price objective (down previously from $26.00) on shares of Kenvue in a research note on Wednesday, October 29th. Edward Jones downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Finally, Rothschild & Co Redburn upgraded Kenvue from a “neutral” rating to a “buy” rating and dropped their target price for the company from $22.50 to $22.00 in a report on Friday, September 26th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, twelve have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus price target of $20.17.

Kenvue Stock Up 2.6%

Shares of NYSE KVUE opened at $16.90 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17. The stock’s 50-day simple moving average is $16.76 and its 200-day simple moving average is $20.30. The firm has a market cap of $32.37 billion, a price-to-earnings ratio of 22.53, a PEG ratio of 2.40 and a beta of 0.71.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The firm had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. During the same quarter last year, the firm earned $0.28 EPS. Kenvue’s quarterly revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th will be given a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.9%. Kenvue’s dividend payout ratio (DPR) is presently 110.67%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.